A review of ramelteon in the treatment of sleep disorders

David N NeubauerDepartment of Psychiatry, Johns Hopkins University School of MedicineAbstract: Ramelteon is a selective melatonin receptor (MT1 and MT2) agonist that has been approved by the US Food and Drug Administration for the treatment of insomnia characterized by difficulty with sleep onset. I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: David N Neubauer
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/9fe37eaa595747798f535232e235e187
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares